Cargando…
Impact of Community Treatment With Ivermectin for the Control of Scabies on the Prevalence of Antibodies to Strongyloides stercoralis in Children
The prevalence of antibodies to Strongyloides stercoralis was measured in 0–12-year-olds using a bead-based immunoassay before and after ivermectin mass drug administration (MDA) for scabies in the Solomon Islands. Seroprevalence was 9.3% before and 5.1% after MDA (P = .019), demonstrating collatera...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7819519/ https://www.ncbi.nlm.nih.gov/pubmed/32421762 http://dx.doi.org/10.1093/cid/ciaa584 |
_version_ | 1783639022692728832 |
---|---|
author | Marks, Michael Gwyn, Sarah Toloka, Hilary Kositz, Christian Asugeni, James Asugeni, Rowena Diau, Jason Kaldor, John M Romani, Lucia Redman-MacLaren, Michelle MacLaren, David Solomon, Anthony W Mabey, David C W Steer, Andrew C Martin, Diana |
author_facet | Marks, Michael Gwyn, Sarah Toloka, Hilary Kositz, Christian Asugeni, James Asugeni, Rowena Diau, Jason Kaldor, John M Romani, Lucia Redman-MacLaren, Michelle MacLaren, David Solomon, Anthony W Mabey, David C W Steer, Andrew C Martin, Diana |
author_sort | Marks, Michael |
collection | PubMed |
description | The prevalence of antibodies to Strongyloides stercoralis was measured in 0–12-year-olds using a bead-based immunoassay before and after ivermectin mass drug administration (MDA) for scabies in the Solomon Islands. Seroprevalence was 9.3% before and 5.1% after MDA (P = .019), demonstrating collateral benefits of ivermectin MDA in this setting. |
format | Online Article Text |
id | pubmed-7819519 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-78195192021-01-25 Impact of Community Treatment With Ivermectin for the Control of Scabies on the Prevalence of Antibodies to Strongyloides stercoralis in Children Marks, Michael Gwyn, Sarah Toloka, Hilary Kositz, Christian Asugeni, James Asugeni, Rowena Diau, Jason Kaldor, John M Romani, Lucia Redman-MacLaren, Michelle MacLaren, David Solomon, Anthony W Mabey, David C W Steer, Andrew C Martin, Diana Clin Infect Dis Brief Reports The prevalence of antibodies to Strongyloides stercoralis was measured in 0–12-year-olds using a bead-based immunoassay before and after ivermectin mass drug administration (MDA) for scabies in the Solomon Islands. Seroprevalence was 9.3% before and 5.1% after MDA (P = .019), demonstrating collateral benefits of ivermectin MDA in this setting. Oxford University Press 2020-05-18 /pmc/articles/PMC7819519/ /pubmed/32421762 http://dx.doi.org/10.1093/cid/ciaa584 Text en © The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Brief Reports Marks, Michael Gwyn, Sarah Toloka, Hilary Kositz, Christian Asugeni, James Asugeni, Rowena Diau, Jason Kaldor, John M Romani, Lucia Redman-MacLaren, Michelle MacLaren, David Solomon, Anthony W Mabey, David C W Steer, Andrew C Martin, Diana Impact of Community Treatment With Ivermectin for the Control of Scabies on the Prevalence of Antibodies to Strongyloides stercoralis in Children |
title | Impact of Community Treatment With Ivermectin for the Control of Scabies on the Prevalence of Antibodies to Strongyloides stercoralis in Children |
title_full | Impact of Community Treatment With Ivermectin for the Control of Scabies on the Prevalence of Antibodies to Strongyloides stercoralis in Children |
title_fullStr | Impact of Community Treatment With Ivermectin for the Control of Scabies on the Prevalence of Antibodies to Strongyloides stercoralis in Children |
title_full_unstemmed | Impact of Community Treatment With Ivermectin for the Control of Scabies on the Prevalence of Antibodies to Strongyloides stercoralis in Children |
title_short | Impact of Community Treatment With Ivermectin for the Control of Scabies on the Prevalence of Antibodies to Strongyloides stercoralis in Children |
title_sort | impact of community treatment with ivermectin for the control of scabies on the prevalence of antibodies to strongyloides stercoralis in children |
topic | Brief Reports |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7819519/ https://www.ncbi.nlm.nih.gov/pubmed/32421762 http://dx.doi.org/10.1093/cid/ciaa584 |
work_keys_str_mv | AT marksmichael impactofcommunitytreatmentwithivermectinforthecontrolofscabiesontheprevalenceofantibodiestostrongyloidesstercoralisinchildren AT gwynsarah impactofcommunitytreatmentwithivermectinforthecontrolofscabiesontheprevalenceofantibodiestostrongyloidesstercoralisinchildren AT tolokahilary impactofcommunitytreatmentwithivermectinforthecontrolofscabiesontheprevalenceofantibodiestostrongyloidesstercoralisinchildren AT kositzchristian impactofcommunitytreatmentwithivermectinforthecontrolofscabiesontheprevalenceofantibodiestostrongyloidesstercoralisinchildren AT asugenijames impactofcommunitytreatmentwithivermectinforthecontrolofscabiesontheprevalenceofantibodiestostrongyloidesstercoralisinchildren AT asugenirowena impactofcommunitytreatmentwithivermectinforthecontrolofscabiesontheprevalenceofantibodiestostrongyloidesstercoralisinchildren AT diaujason impactofcommunitytreatmentwithivermectinforthecontrolofscabiesontheprevalenceofantibodiestostrongyloidesstercoralisinchildren AT kaldorjohnm impactofcommunitytreatmentwithivermectinforthecontrolofscabiesontheprevalenceofantibodiestostrongyloidesstercoralisinchildren AT romanilucia impactofcommunitytreatmentwithivermectinforthecontrolofscabiesontheprevalenceofantibodiestostrongyloidesstercoralisinchildren AT redmanmaclarenmichelle impactofcommunitytreatmentwithivermectinforthecontrolofscabiesontheprevalenceofantibodiestostrongyloidesstercoralisinchildren AT maclarendavid impactofcommunitytreatmentwithivermectinforthecontrolofscabiesontheprevalenceofantibodiestostrongyloidesstercoralisinchildren AT solomonanthonyw impactofcommunitytreatmentwithivermectinforthecontrolofscabiesontheprevalenceofantibodiestostrongyloidesstercoralisinchildren AT mabeydavidcw impactofcommunitytreatmentwithivermectinforthecontrolofscabiesontheprevalenceofantibodiestostrongyloidesstercoralisinchildren AT steerandrewc impactofcommunitytreatmentwithivermectinforthecontrolofscabiesontheprevalenceofantibodiestostrongyloidesstercoralisinchildren AT martindiana impactofcommunitytreatmentwithivermectinforthecontrolofscabiesontheprevalenceofantibodiestostrongyloidesstercoralisinchildren |